Horizon Therapeutics Public Lim Price Today
Horizon Therapeutics Public Lim
HZNP
Healthcare
$22.92B
💰
Market Cap
63.4
💸
Price to Earnings
$1.6
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
3 |
Strong Buy |
3 |
Hold |
7 |
Sell |
0 |
Strong Sell |
0 |
HZNP Price Forecast Target
100.1 👉 116.5 +16%
HZNP EPS Forecast
1.6 👉 6.8 +328%
Financials
Profit Margin
10 %
Revenue Growth
-6.0 %
Dividend
$ 0
Held Percent
1.2% - Insiders
100.9% - Institutions
-2.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $2.4B
-
💰 Blackrock Inc. $1.6B
-
💰 Avoro Capital Advisors LLC $764.0M
-
💰 Pentwater Capital Management Lp $665.8M
-
💰 JP Morgan Chase & Company $598.8M
Stock Ideas
Christopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wi…
David Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhorn’s Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capital’s market beta is around 0.5,…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.📮FAQ
Some Frequently Asked Questions.
The Horizon Therapeutics Public Lim industry is Drug Manufacturers—General
The Horizon Therapeutics Public Lim sector is Healthcare
The Horizon Therapeutics Public Lim forecasted predicted Price to Earnings PE ratio is 14.8
The Horizon Therapeutics Public Lim Price to Earnings PE ratio is 63.4
The Market Capitalization of Horizon Therapeutics Public Lim is $22.92B
There are total of 223596695 float shares with 100.9% held by Institutions and 1.2% held by insiders
The MHorizon Therapeutics Public Lim forecasted Earnings per Share EPS is $6.8
The Horizon Therapeutics Public Lim Earnings per Share EPS is 1.6
The Horizon Therapeutics Public Lim company has $2800556000 gross profits with 10 profit margins
The Horizon Therapeutics Public Lim Earnings Growth is -0.736% with -0.732% quarterly earnings growth
The Horizon Therapeutics Public Lim Revenue is $3575857920 with -0.06 revenue growth
The price target for Horizon Therapeutics Public Lim stock is $116.5 for the high target and $116.5 for the low target
The consensus analyst recommendations for Horizon Therapeutics Public Lim is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Horizon Therapeutics Public Lim is Hold, with the following breakdown:
- Buy: 3
- Strong Buy: 3
- Hold: 7
- Sell: 0
- Strong Sell: 0
The Beta of Horizon Therapeutics Public Lim is 1.1
The dividend of Horizon Therapeutics Public Lim is $0
The dividend yield of Horizon Therapeutics Public Lim is 0%
The biggest institutional and mutual fund holders of Horizon Therapeutics Public Lim stock are
- Vanguard Group Inc
- Blackrock Inc.
- Avoro Capital Advisors LLC
- Pentwater Capital Management Lp
The Horizon Therapeutics Public Lim ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0